1. Home
  2. EXAS vs RGTI Comparison

EXAS vs RGTI Comparison

Compare EXAS & RGTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.54

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Logo Rigetti Computing Inc.

RGTI

Rigetti Computing Inc.

HOLD

Current Price

$26.79

Market Cap

10.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
RGTI
Founded
1995
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
10.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
RGTI
Price
$101.54
$26.79
Analyst Decision
Buy
Strong Buy
Analyst Count
20
6
Target Price
$77.94
$28.33
AVG Volume (30 Days)
10.8M
42.9M
Earning Date
11-03-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,082,033,000.00
$7,494,000.00
Revenue This Year
$19.40
N/A
Revenue Next Year
$13.51
$166.93
P/E Ratio
N/A
N/A
Revenue Growth
14.47
N/A
52 Week Low
$38.81
$5.78
52 Week High
$101.95
$58.15

Technical Indicators

Market Signals
Indicator
EXAS
RGTI
Relative Strength Index (RSI) 89.64 44.96
Support Level $100.95 $24.73
Resistance Level $101.95 $30.21
Average True Range (ATR) 0.34 2.11
MACD -0.87 0.53
Stochastic Oscillator 59.71 46.48

Price Performance

Historical Comparison
EXAS
RGTI

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About RGTI Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.

Share on Social Networks: